GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evolva Holding SA en liquidation (OTCPK:ELVYY) » Definitions » Cyclically Adjusted PS Ratio

Evolva Holding en liquidation (Evolva Holding en liquidation) Cyclically Adjusted PS Ratio : 3.26 (As of May. 21, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Evolva Holding en liquidation Cyclically Adjusted PS Ratio?

As of today (2024-05-21), Evolva Holding en liquidation's current share price is $207.75. Evolva Holding en liquidation's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec22 was $63.80. Evolva Holding en liquidation's Cyclically Adjusted PS Ratio for today is 3.26.

The historical rank and industry rank for Evolva Holding en liquidation's Cyclically Adjusted PS Ratio or its related term are showing as below:

ELVYY' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.14   Med: 4.97   Max: 14.02
Current: 0.21

During the past 13 years, Evolva Holding en liquidation's highest Cyclically Adjusted PS Ratio was 14.02. The lowest was 0.14. And the median was 4.97.

ELVYY's Cyclically Adjusted PS Ratio is ranked better than
95.27% of 507 companies
in the Biotechnology industry
Industry Median: 5.55 vs ELVYY: 0.21

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Evolva Holding en liquidation's adjusted revenue per share data of for the fiscal year that ended in Dec22 was $38.972. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $63.80 for the trailing ten years ended in Dec22.

Shiller PE for Stocks: The True Measure of Stock Valuation


Evolva Holding en liquidation Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Evolva Holding en liquidation's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolva Holding en liquidation Cyclically Adjusted PS Ratio Chart

Evolva Holding en liquidation Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.28 6.61 8.60 6.92 4.55

Evolva Holding en liquidation Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 6.92 - 4.55 -

Competitive Comparison of Evolva Holding en liquidation's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Evolva Holding en liquidation's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Evolva Holding en liquidation's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Evolva Holding en liquidation's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Evolva Holding en liquidation's Cyclically Adjusted PS Ratio falls into.



Evolva Holding en liquidation Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Evolva Holding en liquidation's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=207.75/63.8
=3.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evolva Holding en liquidation's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec22 is calculated as:

For example, Evolva Holding en liquidation's adjusted Revenue per Share data for the fiscal year that ended in Dec22 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec22 (Change)*Current CPI (Dec22)
=38.972/104.6662*104.6662
=38.972

Current CPI (Dec22) = 104.6662.

Evolva Holding en liquidation Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201312 84.748 101.036 87.793
201412 68.475 100.704 71.169
201512 55.893 99.386 58.862
201612 45.168 99.380 47.571
201712 35.943 100.213 37.540
201812 29.240 100.906 30.330
201912 38.315 101.063 39.681
202012 26.946 100.241 28.136
202112 30.469 101.776 31.334
202212 38.972 104.666 38.972

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Evolva Holding en liquidation  (OTCPK:ELVYY) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Evolva Holding en liquidation Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Evolva Holding en liquidation's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Evolva Holding en liquidation (Evolva Holding en liquidation) Business Description

Traded in Other Exchanges
Address
Duggingerstrasse 23, Reinach, CHE, CH-4153
Evolva Holding SA en liquidation formerly Evolva Holding SA is a biotechnology company. The company is engaged in discovering, developing, and commercializing ingredients and biomanufacturing processes for nutrition, healthcare, and wellness products. Geographically, the company operates in Switzerland and the United States where Switzerland derives a majority of its revenue.

Evolva Holding en liquidation (Evolva Holding en liquidation) Headlines

From GuruFocus

Half Year 2023 Evolva Holding SA Earnings Call Transcript

By GuruFocus Research 02-13-2024